In this video, Inderbir S. Gill, MD, discusses data comparing multiple parameters, including intraoperative, perioperative, oncologic, and functional outcomes of open versus robotic surgery
Open surgery is faster for partial nephrectomy, radical prostatectomy, and radical cystectomy. Blood loss, blood transfusions, and length of stay, on the other hand, are lower for all robotic versus open urologic oncologic surgeries.
Those are among the findings of a meta-analysis examining how robotics has impacted the practice of major surgeries performed for urologic cancers. The data were presented by Inderbir S. Gill, MD, of the Keck School of Medicine of the University of Southern California, Los Angeles, at the Society of Urologic Oncology annual meeting in Phoenix.
In this video, Dr. Gill discusses data comparing multiple parameters, including intraoperative, perioperative, oncologic, and functional outcomes of open versus robotic surgery. Financial outcomes and the penetrance of robotics into the specialty since 2000 are also outlined.
“The pendulum is clearly swinging and has swung in favor of robotic surgery,” Dr. Gill said. “About 85% of all prostatectomies in the United States, per the Premier database, are robotic. Sixty-six percent of partial nephrectomies are robotic. Thirty-three percent of radical cystectomies are robotic now; 10 years ago it was only 3%.”
Lenvatinib/pembrolizumab compares favorably with frontline standards in renal cell carcinoma
February 2nd 2024“Combination therapy with lenvatinib plus pembrolizumab provides a comparable OS, and a trend of improvement in PFS and response outcomes, compared with most current global SOC therapies for treatment-naïve patients with advanced renal cell carcinoma,” the study authors wrote.
First-line pembrolizumab/lenvatinib shows efficacy for advanced non–clear cell RCC
January 29th 2024“Updated efficacy and safety results continue to support pembrolizumab plus lenvatinib as a first-line treatment option for patients with advanced non–clear cell RCC,” lead study author Martin H. Voss, MD.